IDH2 and central nervous system cancer: Given that (R)-2HG competitively inhibits 2OG-dependent enzymes, many of which contribute to DNA and histone demethylation, there has been interest in whether methyltransferase inhibitors may be useful in treating IDH-mutant gliomas.